Pamela Rosenthal
Overview
Explore the profile of Pamela Rosenthal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blank R, Haberman R, Qian K, Samanovic M, Castillo R, Jimenez Hernandez A, et al.
Rheumatology (Oxford)
. 2022 May;
62(1):467-472.
PMID: 35640110
Objectives: Autoantibody seroconversion has been extensively studied in the context of COVID-19 infection but data regarding post-vaccination autoantibody production is lacking. Here we aimed to determine the incidence of common...
2.
Plotz B, Castillo R, Melamed J, Nuovo G, Magro C, Rosenthal P, et al.
Rheumatology (Oxford)
. 2021 Jun;
60(7):3485.
PMID: 34096576
No abstract available.
3.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
Ann Rheum Dis
. 2021 May;
80(10):1339-1344.
PMID: 34035003
Objective: To investigate the humoral and cellular immune response to messenger RNA (mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at New...
4.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
medRxiv
. 2021 May;
PMID: 34013285
Objective: To investigate the humoral and cellular immune response to mRNA COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at NYU Langone Health...
5.
Artacho A, Isaac S, Nayak R, Flor-Duro A, Alexander M, Koo I, et al.
Arthritis Rheumatol
. 2020 Dec;
73(6):931-942.
PMID: 33314800
Objective: Although oral methotrexate (MTX) remains the anchor drug for rheumatoid arthritis (RA), up to 50% of patients do not achieve a clinically adequate outcome. In addition, there is a...
6.
Plotz B, Castillo R, Melamed J, Magro C, Rosenthal P, Belmont H
Rheumatology (Oxford)
. 2020 Nov;
60(2):e61-e63.
PMID: 33147605
No abstract available.
7.
Attur M, Krasnokutsky S, Zhou H, Samuels J, Chang G, Bencardino J, et al.
Arthritis Res Ther
. 2020 Sep;
22(1):208.
PMID: 32912331
Objective: Predictive biomarkers of progression in knee osteoarthritis are sought to enable clinical trials of structure-modifying drugs. A peripheral blood leukocyte (PBL) inflammatory gene signature, MRI-based bone marrow lesions (BML)...
8.
Pelzek A, Gronwall C, Rosenthal P, Greenberg J, McGeachy M, Moreland L, et al.
Arthritis Rheumatol
. 2017 Jan;
69(6):1176-1186.
PMID: 28118534
Objective: In rheumatoid arthritis (RA), autoreactive B cells are pathogenic drivers and sources of anti-citrullinated protein antibodies (ACPAs) that are a diagnostic biomarker and predictor of worse long-term prognosis. Yet,...
9.
Krasnokutsky S, Belitskaya-Levy I, Bencardino J, Samuels J, Attur M, Regatte R, et al.
Arthritis Rheum
. 2011 Jun;
63(10):2983-91.
PMID: 21647860
Objective: To evaluate the relationships between both quantitative and semiquantitative assessments of the degree of knee synovitis on 3T magnetic resonance imaging (MRI) and the severity of knee osteoarthritis (OA)...
10.
Pillinger M, Rosenthal P, Abeles A
Bull NYU Hosp Jt Dis
. 2007 Oct;
65(3):215-21.
PMID: 17922673
Over the past decade, significant advances have been made regarding the pathogenesis, clinical implications, and treatment of hyperuricemia. While physicians have understood for at least a century that uric acid...